- Home
- TGL vs RVPH Comparison
TGL vs RVPH Comparison
Compare TGL & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGL
- RVPH
- Stock Information
- Founded
- TGL 2020
- RVPH 2006
- Country
- TGL United States
- RVPH United States
- Employees
- TGL N/A
- RVPH N/A
- Industry
- TGL Retail: Computer Software & Peripheral Equipment
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- TGL Technology
- RVPH Health Care
- Exchange
- TGL Nasdaq
- RVPH Nasdaq
- Market Cap
- TGL 4.1M
- RVPH 32.8M
- IPO Year
- TGL 2022
- RVPH N/A
- Fundamental
- Price
- TGL $1.23
- RVPH $0.39
- Analyst Decision
- TGL
- RVPH Strong Buy
- Analyst Count
- TGL 0
- RVPH 5
- Target Price
- TGL N/A
- RVPH $9.00
- AVG Volume (30 Days)
- TGL 2.9M
- RVPH 2.5M
- Earning Date
- TGL 08-25-2025
- RVPH 08-13-2025
- Dividend Yield
- TGL N/A
- RVPH N/A
- EPS Growth
- TGL N/A
- RVPH N/A
- EPS
- TGL N/A
- RVPH N/A
- Revenue
- TGL $1,468,790.00
- RVPH N/A
- Revenue This Year
- TGL N/A
- RVPH N/A
- Revenue Next Year
- TGL N/A
- RVPH N/A
- P/E Ratio
- TGL N/A
- RVPH N/A
- Revenue Growth
- TGL N/A
- RVPH N/A
- 52 Week Low
- TGL $1.01
- RVPH $0.30
- 52 Week High
- TGL $145.00
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- TGL 43.89
- RVPH 31.05
- Support Level
- TGL $1.22
- RVPH $0.30
- Resistance Level
- TGL $1.11
- RVPH $0.83
- Average True Range (ATR)
- TGL 0.08
- RVPH 0.07
- MACD
- TGL 0.04
- RVPH -0.04
- Stochastic Oscillator
- TGL 62.86
- RVPH 16.04
About TGL Treasure Global Inc.
Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.